CB-04
N/A
Report date: 2023/01/02 17:06:10
NME
Base Information
Drug NameCB-04
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesShanghai Zhimeng Biopharma Inc
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Zhimeng Biopharma Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A